TherapeuticsMD, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 184.2% | 184.2% | -101.7% |
| FY2022 | 318.7% | 318.7% | 123.8% |
| FY2023 | -35.1% | -35.1% | -23.7% |
| FY2024 | -8.0% | -8.0% | -5.6% |
| FY2025 | -2.1% | -2.1% | -1.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 184.2% | 184.2% | -101.7% |
| FY2022 | 318.7% | 318.7% | 123.8% |
| FY2023 | -35.1% | -35.1% | -23.7% |
| FY2024 | -8.0% | -8.0% | -5.6% |
| FY2025 | -2.1% | -2.1% | -1.5% |